1Institute for Aerospace Studies, University of Toronto
2Nicholas School of Environment, Duke University
3Global Institute of Health, Duke University
4Gillings School of Global Public Health, University of North Carolina
5Department of Medicine, Division of Infectious Diseases, University of Toronto
6The Fields Institute for Research in Mathematical Sciences
7Department of Mathematics, University of Toronto
2 ≤ R0 ≤ 3.6
1 - expectation
2 - greater variability
8 - non-random pattern of clustering
10 - 10-20% of index cases responsible for 80% of secondary cases
11 - Agent based modeling by Sneppen et al.
12 - Chen et al.
13 - airborne transmission of SARS-CoV-2 by respiratory aerosols
14 - airborne transmission of SARS-CoV-2 by respiratory aerosols
15 - airborne transmission of SARS-CoV-2 by respiratory aerosols
16 - airborne transmission of SARS-CoV-2 by respiratory aerosols
17 - airborne transmission of SARS-CoV-2 by respiratory aerosols
18 - Prather et al.
19 - encapsulating the SARS-CoV-2 virus
20 - infectious within the aerosols
21 - Bourouiba et al.
22 - Abkarian et al.
23 - Chen et al.
19 - Chaudhuri et al.
24, Wells-Riley model
25, Wells-Riley model
26, Buonanno et al.
27, Bazant and Bush
28, Schijven et al.
29, Bond et al.
30, Recent review and opinion articles
31, Recent review and opinion articles
32, Recent review and opinion articles
33, Recent review and opinion articles
34, Recent review and opinion articles
10 - DT = A × (0.52 × ACH + 0.32)/3600
11 - Nv(x, y, z0, τ ) = ∫τ 0 c(x, y, z0, t ) ˙Vbdt 
None
1. Lloyd-Smith et al. [1]
2. Figure 8
3. Figure 9
4. Eqn. 12
5. Eqn. 15
6. Eqn. 16

None
24 - viral load
25 - Eqn. 22
None
g(µ = 20.67, σ = 3.63, α = 1.123 × 10−10, ν = 7.71)
ACH = 5 hr−1
50% reduction by volume of exhaled aerosols
50% reduction in the correspondingly inhaled aerosols
α = 2.36 × 10−11
α = 2.81 × 10−11
νv = 4.01
νv = 2.00
Z = 0.04
Z = 1.69
Z = 2.64
None
Mean viral load, mean occupancy, and mean ventilation rates: 0.6, 0.8, 4.01
Vaccine efficacy ηvac: 0.6
Vaccination coverage efficiency ηcov: 0.8
Reduced occupancy: 50%
Masks that can reduce both emission and inhalation of aerosol volumes by 50%: 50%
[9] G. Großmann, M. Backenk¨ohler, and V. Wolf, “Heterogeneity matters: Contact struc- ture and individual variation shape epidemic dynamics,” Plos one, vol. 16, no. 7, p. e0250050, 2021.
[10] P. Z. Chen, N. Bobrovitz, Z. Premji, M. Koopmans, D. N. Fisman, and F. X. Gu, “Heterogeneity in transmissibility and shedding sars-cov-2 via droplets and aerosols,”
Elife, vol. 10, p. e65774, 2021.
[11] K. Sneppen, B. F. Nielsen, R. J. Taylor, and L. Simonsen, “Overdispersion in covid-19 increases the eﬀectiveness of limiting nonrepetitive contacts for transmission control,”
Proceedings of the National Academy of Sciences, vol. 118, no. 14, 2021.
[12] P. Z. Chen, M. Koopmans, D. N. Fisman,
24 E. Riley, G. Murphy, and R. Riley, “Airborne spread of measles in a suburban elementary school,” American journal of epidemiology, vol. 107, no. 5, pp. 421–432, 1978.
25 S. Rudnick and D. Milton, “Risk of indoor airborne infection transmission estimated from carbon dioxide concentration,” Indoor air, vol. 13, no. 3, pp. 237–245, 2003.
26 G. Buonanno, L. Morawska, and L. Stabile, “Quantitative assessment of the risk of air- borne transmission of sars-cov-2 infection: prospective and retrospective applications,” Environment international, vol. 145, p. 106112, 2020.
27 M. Z. Bazant and J. W. Bush, “A guideline to limit indoor airborne transmission of covid-19,” Proceedings of the National Academy of Sciences, vol. 118, no. 17, 2021.
28 J. Schijven, L. C. Vermeulen, A. Swart, A. Meijer, E. Duizer, and A. M. de Rod
35 - Xiong, Z. Liu, Q. Guo, L. Zou, H. Zhang, M. Zhang, F. Ouyang, J. Su, W. Su, J. Xu, H. Lin, J. Sun, J. Peng, H. Jiang, P. Zhou, T. Hu, M. Luo, Y. Zhang, H. Zheng, J. Xiao, T. Liu, R. Che, H. Zeng, Z. Zheng, Y. Huang, J. Yu, L. Yi, J. Wu, J. Chen, H. Zhong, X. Deng, M. Kang, O. G. Pybus, M. Hall, K. A. Lythgoe, Y. Li, J. Yuan, J. He, and J. Lu, “Viral infection and transmis- sion in a large, well-traced outbreak caused by the sars-cov-2 delta variant,” medRxiv, 2021.
36 - M. C. Shamier, A. Tostmann, S. Bogers, J. De Wilde, J. IJpelaar, W. A. van der
